Leaflet GLUCOTROL XL 10mg modified release tablets

Indicated for: type 2 diabetes mellitus

Route of administration: oral

Substance: glipizide (sulfonylurea antidiabetic)

ATC: A10BB07 (Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Sulfonylureas)

Precautions:
Hypoglycemia
Hypoglycemia

This medicine may lower blood sugar.

Glipizide is an antidiabetic medication from the sulfonylurea class, used to control blood sugar levels in patients with type 2 diabetes. It works by stimulating the pancreas to produce more insulin, thereby helping to lower blood sugar levels.

It is recommended as part of a treatment plan that includes a balanced diet, regular physical activity, and blood sugar monitoring. Glipizide is effective in reducing the risk of diabetes-related complications, such as damage to small blood vessels (retinopathy, nephropathy).

Side effects may include hypoglycemia (excessive drop in blood sugar), nausea, dizziness, weight gain, or allergic reactions. It is important for patients to follow the prescribed dosage and watch for signs of hypoglycemia, such as shaking, sweating, or confusion.

General data about GLUCOTROL XL 10mg

  • Substance: glipizide
  • Date of latest medicines list: 01-06-2026
  • Product code: W65039001
  • Concentration: 10mg
  • Pharmaceutical form: modified release tablets
  • Quantity: 30
  • Product type: Original
  • Price: 58.83 RON
  • Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

  • Manufacturer: FAREVA AMBOISE - FRANTA
  • Holder: PFIZER EUROPE MA EEIG - BELGIA
  • Number: 12730/2019/01
  • Shelf life: 3 years

Pharmaceutical forms available for glipizide

Concentrations available for glipizide

  • 10mg
  • 5mg

Compensation lists for GLUCOTROL XL 10mg Pfizer

NHP 5 (C2) - Diabetes

Price

Copayment

Patient

58.83 RON

58.83 RON

0.00 RON